Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3203)
All Articles published online
|
Publishing Process of This Article
|
Feb 16, 2022 (publication date) through Jul 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang J, Gao YS, Xu K, Li XD. Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report. World J Clin Cases 2022; 10(5): 1609-1616 [PMID: 35211600 DOI: 10.12998/wjcc.v10.i5.1609] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i5/1609.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Shuhui Zhuang, Zhaobo Yang, Zhuangzhuang Cui, Yuanyuan Zhang, Fengyuan Che. Epigenetic alterations and advancement of lymphoma treatment. Annals of Hematology 2024; 103(5): 1435 doi: 10.1007/s00277-023-05395-z
|
| 3 |
Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao, Yanyan Liu. Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1088685
|
| 4 |
Ajay Major, Pierluigi Porcu, Bradley M. Haverkos. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. Cancers 2023; 15(5): 1366 doi: 10.3390/cancers15051366
|